Drug Profile
HDV Biotin - Diasome Pharmaceuticals
Alternative Names: Oral HDV biotinLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Diasome Pharmaceuticals
- Class Anti-inflammatories; Carboxylic acids; Coenzymes; Imidazoles; Small molecules; Vitamins
- Mechanism of Action Enzyme replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Obesity
Most Recent Events
- 17 Jan 2018 HDV biotin is still in phase II trial for Obesity in USA (Diasome Pharmaceuticals pipeline, January 2018)
- 11 Dec 2015 Phase-II clinical trials in Obesity in USA (PO) (Diasome Pharmaceuticals pipeline, December 2015)